BKV (NYSE:BKV) Price Target Raised to $26.00

BKV (NYSE:BKV - Free Report) had its price objective increased by Evercore ISI from $20.00 to $26.00 in a research report sent to investors on Friday morning,Benzinga reports. Evercore ISI currently has an outperform rating on the stock.

Several other equities analysts have also recently issued reports on the company. Truist Financial decreased their price objective on BKV from $31.00 to $30.00 and set a "buy" rating for the company in a research note on Monday, March 17th. Barclays raised their target price on BKV from $28.00 to $29.00 and gave the stock an "overweight" rating in a research report on Monday, May 12th. Finally, KeyCorp cut their price target on BKV from $27.00 to $25.00 and set an "overweight" rating on the stock in a research report on Tuesday, March 4th. Eight research analysts have rated the stock with a buy rating, According to MarketBeat, BKV currently has an average rating of "Buy" and a consensus target price of $28.13.

BKV Stock Down 1.8%

Shares of BKV traded down $0.39 during midday trading on Friday, reaching $21.48. The company had a trading volume of 500,500 shares, compared to its average volume of 452,594. BKV has a 1-year low of $15.00 and a 1-year high of $26.78. The firm has a 50 day simple moving average of $19.40 and a 200-day simple moving average of $21.45.

BKV (NYSE:BKV - Get Free Report) last issued its quarterly earnings data on Friday, May 9th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.15 by $0.26. The business had revenue of $216.13 million for the quarter, compared to analyst estimates of $223.20 million. As a group, equities analysts forecast that BKV will post -1.82 EPS for the current year.

Insider Buying and Selling

In other news, insider Ethan Ngo sold 21,667 shares of the company's stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $20.09, for a total value of $435,290.03. Following the sale, the insider now directly owns 286,008 shares in the company, valued at $5,745,900.72. This represents a 7.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO David Tameron sold 5,000 shares of the company's stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $20.03, for a total value of $100,150.00. Following the completion of the sale, the chief financial officer now owns 47,779 shares in the company, valued at $957,013.37. This represents a 9.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 173,777 shares of company stock valued at $3,602,199 over the last quarter.

Institutional Trading of BKV

Institutional investors and hedge funds have recently made changes to their positions in the stock. Geode Capital Management LLC purchased a new stake in shares of BKV in the fourth quarter valued at $7,728,000. Bank of New York Mellon Corp purchased a new position in BKV during the fourth quarter worth about $695,000. Driehaus Capital Management LLC purchased a new position in BKV during the fourth quarter worth about $9,553,000. SG Americas Securities LLC purchased a new position in BKV during the fourth quarter worth about $157,000. Finally, Corebridge Financial Inc. purchased a new position in BKV during the fourth quarter worth about $170,000.

BKV Company Profile

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.